{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:54:09Z","timestamp":1791420849854,"version":"4.3.3"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jpba.2016.07.009","type":"journal-article","created":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T07:35:46Z","timestamp":1467963346000},"page":"441-449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"special_numbering":"C","title":["A novel screening method for 64 new psychoactive substances and 5 amphetamines in blood by LC\u2013MS\/MS and application to real cases"],"prefix":"10.1016","volume":"129","author":[{"given":"Fabio","family":"Vaiano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3082-4532","authenticated-orcid":false,"given":"Francesco P.","family":"Busard\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrystalla","family":"Kyriakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Fioravanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Catalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Mari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Bertol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2016.07.009_bib0005","first-page":"3270","article-title":"NBOMe: new potent hallucinogens\u2013pharmacology, analytical methods, toxicities, fatalities: a review","volume":"19","author":"Kyriakou","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.jpba.2016.07.009_bib0010","article-title":"Simple and rapid screening procedure for 143 new psychoactive substances by liquid chromatography\u2013tandem mass spectrometry","author":"Adamowicz","year":"2015","journal-title":"Drug Test Anal."},{"key":"10.1016\/j.jpba.2016.07.009_bib0015","unstructured":"EMCDDA, European Drug Report 2014: Trends and developments European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/963\/TDAT14001ENN.pdf (accessed 20.01.16)."},{"key":"10.1016\/j.jpba.2016.07.009_bib0020","unstructured":"EMCDDA, European Drug Report 2015: Trends and developments European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/974\/TDAT15001ENN.pdf (accessed 20.01.16)."},{"key":"10.1016\/j.jpba.2016.07.009_bib0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.drugalcdep.2014.11.033","article-title":"Monitoring new psychoactive substances (NPS) in The Netherlands: data from the drug market and the Poisons Information Centre","volume":"147","author":"Hondebrink","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jpba.2016.07.009_bib0030","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.forsciint.2016.01.015","article-title":"Levamisole adulterated cocaine and pulmonary vasculitis: presentation of two lethal cases and brief literature review","volume":"265","author":"Karch","year":"2016","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2016.07.009_bib0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.forsciint.2015.07.021","article-title":"Assessment of the stability of mephedrone in ante-mortem and post-mortem blood specimens","volume":"256","author":"Busardo","year":"2015","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2016.07.009_bib0040","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.forsciint.2010.12.014","article-title":"A case of extreme agitation and death after the use of mephedrone in The Netherlands","volume":"206","author":"Lusthof","year":"2011","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2016.07.009_bib0045","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1016\/j.forsciint.2010.07.014","article-title":"The detection of mephedrone (4-methylmethcathinone) in 4 fatalities in Scotland","volume":"202","author":"Torrance","year":"2010","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2016.07.009_bib0050","first-page":"3777","article-title":"Mephedrone related fatalities: a review","volume":"19","author":"Busardo","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.jpba.2016.07.009_bib0055","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3109\/15563650.2014.981823","article-title":"Characteristics of analytically confirmed 3-MMC-related intoxications from the Swedish STRIDA project","volume":"53","author":"Backberg","year":"2015","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.jpba.2016.07.009_bib0060","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.forsciint.2014.08.002","article-title":"A mixed MDPV and benzodiazepine intoxication in a chronic drug abuser: determination of MDPV metabolites by LC\u2013HRMS and discussion of the case","volume":"243","author":"Bertol","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2016.07.009_bib0065","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11419-015-0270-0","article-title":"Comprehensive review of the detection methods for synthetic cannabinoids and cathinones","volume":"33","author":"Namera","year":"2015","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.jpba.2016.07.009_bib0070","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000346678","article-title":"Do novel psychoactive substances displace established club drugs supplement them or act as drugs of initiation? The relationship between mephedrone, ecstasy and cocaine","volume":"19","author":"Moore","year":"2013","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.jpba.2016.07.009_bib0075","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/dta.1610","article-title":"New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?","volume":"6","author":"Gine","year":"2014","journal-title":"Drug Test Anal."},{"key":"10.1016\/j.jpba.2016.07.009_bib0080","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/0025802413477396","article-title":"Screening for synthetic cannabinoids in hair by using LC\u2013QTOF MS: a new and powerful approach to study the penetration of these new psychoactive substances in the population","volume":"54","author":"Gottardo","year":"2014","journal-title":"Med. Sci. Law"},{"key":"10.1016\/j.jpba.2016.07.009_bib0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jchromb.2015.07.007","article-title":"High-throughput screening for new psychoactive substances (NPS) in whole blood by DLLME extraction and UHPLC\u2013MS\/MS analysis","volume":"1000","author":"Odoardi","year":"2015","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2016.07.009_bib0090","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.chroma.2015.04.002","article-title":"Simultaneous determination of 40 novel psychoactive stimulants in urine by liquid chromatography\u2013high resolution mass spectrometry and library matching","volume":"1397","author":"Concheiro","year":"2015","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2016.07.009_bib0095","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s00216-009-3394-4","article-title":"LC\u2013MS\/MS screening method for designer amphetamines, tryptamines, and piperazines in serum","volume":"396","author":"Wohlfarth","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2016.07.009_bib0100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.chroma.2014.10.106","article-title":"Screening for new psychoactive substances in hair by ultrahigh performance liquid chromatography\u2013electrospray ionization tandem mass spectrometry","volume":"1372C","author":"Strano-Rossi","year":"2014","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2016.07.009_bib0105","article-title":"An LC\u2013MS\/MS methodological approach to the analysis of hair for amphetamine-type-stimulant (ATS) drugs, including selected synthetic cathinones and piperazines","author":"Lendoiro","year":"2016","journal-title":"Drug Test Anal."},{"key":"10.1016\/j.jpba.2016.07.009_bib0110","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.forsciint.2013.11.004","article-title":"Development and validation of a single LC\u2013MS\/MS assay following SPE for simultaneous hair analysis of amphetamines opiates, cocaine and metabolites","volume":"234","author":"Imbert","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2016.07.009_bib0115","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jchromb.2014.08.033","article-title":"Simultaneous detection of 93 conventional and emerging drugs of abuse and their metabolites in urine by UHPLC\u2013MS\/MS","volume":"969","author":"Tang","year":"2014","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2016.07.009_bib0120","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s00216-015-9247-4","article-title":"Determination of cathinones and other stimulant, psychedelic, and dissociative designer drugs in real hair samples","volume":"408","author":"Salomone","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2016.07.009_bib0125","first-page":"37","article-title":"Emerging drugs of abuse: current perspectives on substituted cathinones","volume":"5","author":"Paillet-Loilier","year":"2014","journal-title":"Subst. Abuse Rehabil."},{"key":"10.1016\/j.jpba.2016.07.009_bib0130","first-page":"53","article-title":"Pharmacology, toxicology, and adverse effects of synthetic cannabinoid drugs","volume":"26","author":"Gurney","year":"2014","journal-title":"Forensic Sci. Rev."},{"key":"10.1016\/j.jpba.2016.07.009_bib0135","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/jat\/bkt063","article-title":"Comparison of immunoassay screening tests and LC\u2013MS\u2013MS for urine detection of benzodiazepines and their metabolites: results of a national proficiency test","volume":"37","author":"Bertol","year":"2013","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2016.07.009_bib0140","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jpba.2013.05.026","article-title":"Cross-reactivities and structure-reactivity relationships of six benzodiazepines to EMIT((R)) immunoassay","volume":"84","author":"Bertol","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2016.07.009_bib0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.forsciint.2015.07.018","article-title":"In vivo detection of the new psychoactive substance AM-694 and its metabolites","volume":"256","author":"Bertol","year":"2015","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2016.07.009_bib0150","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/dta.1657","article-title":"A simple extraction and LC\u2013MS\/MS approach for the screening and identification of over 100 analytes in eight different matrices","volume":"7","author":"Montenarh","year":"2015","journal-title":"Drug Test Anal."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708516303818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708516303818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T13:29:30Z","timestamp":1536586170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708516303818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":30,"alternative-id":["S0731708516303818"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2016.07.009","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel screening method for 64 new psychoactive substances and 5 amphetamines in blood by LC\u2013MS\/MS and application to real cases","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2016.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}